# Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft

> **NCT02430558** · PHASE1,PHASE2 · TERMINATED · sponsor: **TBF Genie Tissulaire** · enrollment: 10 (actual)

## Conditions studied

- Cartilage Injury

## Interventions

- **BIOLOGICAL:** OD-PHOENIX

## Key facts

- **NCT ID:** NCT02430558
- **Lead sponsor:** TBF Genie Tissulaire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04-05
- **Primary completion:** 2021-06-15
- **Final completion:** 2021-06-15
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Low accrual rate
- **Last updated:** 2022-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02430558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02430558, "Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02430558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*